CYCLOSET (bromocriptine mesylate)
ANTIHYPERGLYCEMIC - DOPAMINE RECEPTOR AGONISTS · TYPE 2 DIABETES MELLITUS TREATMENT ADJUNCT
SANTARUS INC/SA
Drug class
Antihyperglycemic - Dopamine Receptor Agonists
Antihyperglycemic dopamine receptor agonists are a specialized subcategory of dopamine receptor agonists utilized as adjunct therapy to diet and exercise for glycemic control in adults with type 2 diabetes mellitus. Read more about Antihyperglycemic - Dopamine Receptor Agonists
2 drugs in this class 2 manufacturers
Drugs in Antihyperglycemic - Dopamine Receptor Agonists
CYCLOSET (bromocriptine mesylate)
ANTIHYPERGLYCEMIC - DOPAMINE RECEPTOR AGONISTS · TYPE 2 DIABETES MELLITUS TREATMENT ADJUNCT
AVVISTO THERAPE
Filter & compare in the drug finder →
Opens the drug finder with Antihyperglycemic - Dopamine Receptor Agonists preselected. Add indication or manufacturer filters there.
Antihyperglycemic dopamine receptor agonists are a specialized subcategory of dopamine receptor agonists utilized as adjunct therapy to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.
Represented primarily by quick-release bromocriptine mesylate, these agents act centrally on hypothalamic dopamine D2 receptors to reset blunted circadian dopaminergic rhythms.
This central dopaminergic stimulation reduces elevated sympathetic tone, which suppresses excessive hepatic glucose production and ameliorates peripheral insulin resistance without stimulating pancreatic insulin secretion.
-
healio.com
Antihyperglycemic dopamine receptor agonists are a specialized subcategory of dopamine receptor agonists utilized as adjunct therapy to diet and exercise for glycemic control in adults with type 2 diabetes mellitus Represented primarily by quick-release bromocriptine mesylate, these agents act centrally on hypothalamic dopamine D2 receptors to reset blunted circadian dopaminergic rhythms This central dopaminergic stimulation reduces elevated sympathetic tone, which suppresses excessive hepatic g...
-
medlineplus.gov
Antihyperglycemic dopamine receptor agonists are a specialized subcategory of dopamine receptor agonists utilized as adjunct therapy to diet and exercise for glycemic control in adults with type 2 diabetes mellitus
-
endocrine.plus
Represented primarily by quick-release bromocriptine mesylate, these agents act centrally on hypothalamic dopamine D2 receptors to reset blunted circadian dopaminergic rhythms This central dopaminergic stimulation reduces elevated sympathetic tone, which suppresses excessive hepatic glucose production and ameliorates peripheral insulin resistance without stimulating pancreatic insulin secretion
-
diabetesjournals.org
This central dopaminergic stimulation reduces elevated sympathetic tone, which suppresses excessive hepatic glucose production and ameliorates peripheral insulin resistance without stimulating pancreatic insulin secretion
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.